309 related articles for article (PubMed ID: 27770867)
21. Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property.
Onoue S; Ochi M; Yamada S
Int J Pharm; 2011 May; 410(1-2):111-3. PubMed ID: 21419204
[TBL] [Abstract][Full Text] [Related]
22. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant Nanocomplexes for Delivery of Epigallocatechin-3-gallate.
Hu B; Ma F; Yang Y; Xie M; Zhang C; Xu Y; Zeng X
J Agric Food Chem; 2016 May; 64(17):3422-9. PubMed ID: 27064900
[TBL] [Abstract][Full Text] [Related]
24. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
[TBL] [Abstract][Full Text] [Related]
25. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
26. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate.
Hu B; Ting Y; Zeng X; Huang Q
J Agric Food Chem; 2013 Jan; 61(4):875-81. PubMed ID: 23293838
[TBL] [Abstract][Full Text] [Related]
27. Conjugation of (-)-epigallocatechin-3-gallate and protein isolate from large yellow croaker (Pseudosciaena crocea) roe: improvement of antioxidant activity and structural characteristics.
Du YN; Han JR; Yin ZK; Yan JN; Jiang XY; Wu HT
J Sci Food Agric; 2021 Nov; 101(14):5948-5955. PubMed ID: 33838054
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the Effect of Different Emulsifiers on the Transdermal Delivery of EGCG Entrapped in a Polymeric Micelle System.
Casiraghi A; Franzè S; Selmin F; Dazio V; Minghetti P
Planta Med; 2017 Mar; 83(5):405-411. PubMed ID: 27286328
[TBL] [Abstract][Full Text] [Related]
29. On the role of epigallocatechin-3-gallate in protecting phospholipid molecules against UV irradiation.
Pires F; Geraldo VPN; Antunes A; Marletta A; Oliveira ON; Raposo M
Colloids Surf B Biointerfaces; 2019 Jan; 173():312-319. PubMed ID: 30308456
[TBL] [Abstract][Full Text] [Related]
30. Liposomal Formulations for an Efficient Encapsulation of Epigallocatechin-3-gallate: An in- Silico/Experimental Approach.
Laudadio E; Minnelli C; Amici A; Massaccesi L; Mobbili G; Galeazzi R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462955
[TBL] [Abstract][Full Text] [Related]
31. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate.
Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y
Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300
[TBL] [Abstract][Full Text] [Related]
32. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
33. Co-Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity.
Chen W; Zou M; Ma X; Lv R; Ding T; Liu D
J Food Sci; 2019 Jan; 84(1):111-120. PubMed ID: 30548488
[TBL] [Abstract][Full Text] [Related]
34. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
[TBL] [Abstract][Full Text] [Related]
36. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
de Pace RC; Liu X; Sun M; Nie S; Zhang J; Cai Q; Gao W; Pan X; Fan Z; Wang S
J Liposome Res; 2013 Sep; 23(3):187-96. PubMed ID: 23600473
[TBL] [Abstract][Full Text] [Related]
37. Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.
Chen X; Yu H; Shen S; Yin J
J Trace Elem Med Biol; 2007; 21(2):125-31. PubMed ID: 17499153
[TBL] [Abstract][Full Text] [Related]
38. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Siddiqui IA; Adhami VM; Bharali DJ; Hafeez BB; Asim M; Khwaja SI; Ahmad N; Cui H; Mousa SA; Mukhtar H
Cancer Res; 2009 Mar; 69(5):1712-6. PubMed ID: 19223530
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
[TBL] [Abstract][Full Text] [Related]
40. The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression.
Navarro-Perán E; Cabezas-Herrera J; Sánchez-Del-Campo L; García-Cánovas F; Rodríguez-López JN
Inflamm Res; 2008 Oct; 57(10):472-8. PubMed ID: 18830563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
